- Sustained virological response with telaprevir in 1078 patients with advanced hepatitis C: The international telaprevir access program2014 | First Faculty of Medicine
- Randomized trial of peginterferon alfa-2b and ribavirin for 48 or 72 weeks in patients with hepatitis C virus genotype 1 and slow virologic response2010 | Faculty of Medicine in Pilsen
- Efficacy and safety of peginterferon alpha-2a (40KD) plus ribavirin in treatment-naive chronic hepatitis C patients in Central and Eastern Europe2011 | First Faculty of Medicine
- Safety and effectiveness of chronic hepatitis C virus infection treatment with fixed combination of sofosbuvir ande velpatasvir (Epclusa(R))2016 | First Faculty of Medicine
- Establishing a hepatitis C continuum of care among HIV/hepatitis C virus-coinfected individuals in EuroSIDA2019 | Faculty of Medicine in Pilsen
- USP18 downregulation in peripheral blood mononuclear cells predicts nonresponse to interferon-based triple therapy in patients with chronic hepatitis C, genotype 1: a pilot study2015 | First Faculty of Medicine, Central Library of Charles University
- Safety and on-treatment efficacy of telaprevir: the early access programme for patients with advanced hepatitis C2014 | First Faculty of Medicine
- Final Results of the Telaprevir Access Program: FibroScan Values Predict Safety and Efficacy in Hepatitis C Patients with Advanced Fibrosis or Cirrhosis2015 | First Faculty of Medicine
- Telaprevir2012 | Faculty of Medicine in Pilsen
- Anemia as a predictor of response to antiviral therapy in chronic hepatitis C2013 | First Faculty of Medicine, Central Library of Charles University
- Response of HIV positive patients to the long-term salvage therapy by lopinavir/ritonavir.2005 | Faculty of Science
- Retreatment with peginterferon plus ribavirin in chronic hepatitis C patients: our own experiences2010 | Faculty of Science
- Relevance of low viral load in haemodialysed patients with chronic hepatitis C virus infection2015 | Faculty of Medicine in Pilsen, Central Library of Charles University
- Treatment of chronic hepatitis B with adefovir dipivoxile2005 | Third Faculty of Medicine
- Treatment of chronic hepatitis C - refractory forms2014 | First Faculty of Medicine
- In vitro susceptibility of adenovirus to antiviral drugs in species-dependent2005 | Second Faculty of Medicine
- Pilot Outreach Program in Remedis-The Promising Step toward HCV Elimination among People Who Inject Drugs2023 | First Faculty of Medicine
- Closed tube method for rapid screening of IL28B polymorphisms involved in response to hepatitis C treatment2012 | Second Faculty of Medicine
- Targeted treatment of metastatic melanoma in a drug-addicted patient with pre-existing hepatitis C2019 | Third Faculty of Medicine
- Diagnosis and therapy of chronic hepatitis D: Czech national guidelines. The date of release: 2023 +12023 | First Faculty of Medicine
- Factors associated with uptake, adherence, and efficacy of hepatitis C treatment in people who inject drugs: a literature review2013 | First Faculty of Medicine
- Therapy of chronic hepatitis C in people who inject drugs: focus on adherence2021 | First Faculty of Medicine, Faculty of Physical Education and Sport
- Expression of Biliverdin Reductase A in Peripheral Blood Leukocytes Is Associated with Treatment Response in HCV-Infected Patients2013 | First Faculty of Medicine
- Combination of sofosbuvir and daclatasvir in the treatment of genotype 3 chronic hepatitis C virus infection in patients on maintenance hemodialysis2017 | First Faculty of Medicine
- Paritaprevir/Ritonavir/Ombitasvir Plus Dasabuvir Regimen in the Treatment of Genotype 1 Chronic Hepatitis C Infection in Patients with Severe Renal Impairment and End-Stage Renal Disease: a Real-Life Cohort2018 | First Faculty of Medicine
- Glecaprevir/pibrentasvir for 8 weeks in treatment-naive patients with chronic HCV genotypes 1-6 and compensated cirrhosis: The EXPEDITION-8 trial2020 | First Faculty of Medicine